Einträge von Bahlinger, Veronika auf dem Publikationsserver

Haas, Maximilian , Mayr, Roman , Sikic, Danijel, Wullich, Bernd, Klümper, Niklas, Erben, Philipp, Wirtz, Ralph, Bolenz, Christian, Roghmann, Florian, Stöhr, Robert, Bahlinger, Veronika, Hartmann, Arndt, Burger, Maximilian, Breyer, Johannes und Eckstein, Markus (2025) Clinical and Genomic Landscape of FGFR3 Alterations Across Different Stages of Urothelial Cancer. European Urology Open Science 77, S. 1-9.

Haas, Maximilian , Kriegmair, Maximilian C., Breyer, Johannes , Sikic, Danijel, Wezel, Felix, Roghmann, Florian, Brehmer, Mirco, Wirtz, Ralph M., Jarczyk, Jonas, Erben, Philipp, Bahlinger, Veronika, Goldschmidt, Franziska, Fechner, Guido, Chen, Jack, Paxinos, Ellen, Bates, Michael, Zengerling, Friedemann, Bolenz, Christian, Burger, Maximilian, Hartmann, Arndt und Eckstein, Markus (2024) Improving detection of carcinoma in situ in bladder cancer: urinary cytology vs the Xpert® BC Monitor. BJU International.

Breyer, Johannes, Eckstein, Markus, Sikic, Danijel, Wezel, Felix, Roghmann, Florian, Brehmer, Mirco, Wirtz, Ralph M., Jarczyk, Jonas, Erben, Philipp, Bahlinger, Veronika, Goldschmidt, Franziska, Fechner, Guido, Chen, Jack, Paxinos, Ellen, Bates, Michael, Haas, Maximilian, Zengerling, Friedemann, Bolenz, Christian, Burger, Maximilian, Hartmann, Arndt, Kriegmair, Maximilian C. und BRIDGE Consortium e.V., . (2023) Xpert bladder cancer monitor to predict the need for a second TURB (MoniTURB trial). Scientific Reports 13 (1).

Erlmeier, Franziska, Klümper, Niklas, Landgraf, Laura, Strissel, Pamela L., Strick, Reiner, Sikic, Danijel, Taubert, Helge, Wach, Sven, Geppert, Carol I., Bahlinger, Veronika, Breyer, Johannes, Ritter, Manuel, Bolenz, Christian, Roghmann, Florian, Erben, Philipp, Schwamborn, Kristina, Wirtz, Ralph M., Horn, Thomas, Wullich, Bernd, Hölzel, Michael, Hartmann, Arndt, Gschwend, Jürgen E., Weichert, Wilko und Eckstein, Markus (2023) Spatial Immunephenotypes of Distant Metastases but not Matched Primary Urothelial Carcinomas Predict Response to Immune Checkpoint Inhibition. European Urology 83 (2), S. 133-142. Volltext nicht vorhanden.